nach oben

Erschienen in:

2022 | OriginalPaper | Buchkapitel

2. Schmerz und Schmerzhemmung

verfasst von : Pieter van Kerkhof

Erschienen in: Evidenzbasierte Elektrotherapie

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

In diesem Kapitel wird auf verschiedene Aspekte von Schmerz und der Schmerzhemmung eingegangen. Hemmungsmechanismen werden erklärt und Konsequenzen für die Therapie werden erörtert. Es wird auf die Stressreaktion eingegangen, da die Ausrichtung des vegetativen Nervensystems die Wahl einer Therapieanwendung beeinflusst. Nur wenn der behandelnde Therapeut selbst über ein Grundverständnis dieser Materie verfügt, kann er dies seinen Patienten glaubwürdig und auf angemessene Weise vermitteln. Der Großteil unserer Patienten kommt zu uns wegen Schmerzen. Wir wissen, dass für den Patienten Information über deren Hauptproblem von größter Bedeutung ist. Dies gilt ganz besonders für Patienten mit chronischen Schmerzen. Wir wissen auch, dass Information, falls diese wie allgemein üblich über anatomische und biomechanische Aspekte vermittelt wird, eher beschränkt wirksam ist. Diese Art von Information wird heutzutage assoziiert mit der Entwicklung von Angstverhalten, Katastrophisierung und falschen Vorstellungen über die dem Schmerz zugrundeliegende Problematik (Louw A, Diener I, Butler DS, Puentedura EJ (2011) The effect of neuroscience education on pain, disability, anxiety, and stress in chronic musculoskeletal pain. Arch Phys Med Rehabil 92:2041–2056; Sloan TJ, Walsh DA (2010) Explanatory and diagnostic labels and perceived prognosis in chronic low back pain. Spine 35(21):1120–1125; Louw A, Zimney K, O’Hotto C, Hilton S (2016) The clinical application of teaching people about pain. Physiother Theory Pract 5:385–395). Deshalb wird auch auf die sog. Pain Neuroscience Education eingegangen.

Vorheriges Kapitel Geschichtliches

Nächstes Kapitel Reizleitung

Alles SRA, Smith PA (2018) Etiology and pharmacology of neuropathic pain. Pharmacol Rev 70:315–347PubMedCrossRef

Anand P, Bley K (2011) Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch. Br J Anaesth 107(4):490–502PubMedPubMedCentralCrossRef

Backonja M, Wallace MS, Blonsky ER, Cutler BJ, Malan P Jr, Rauck R, Tobias J (2008) NGX-4010 C116 Study Group. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study. Lancet Neurol 7(12):1106–1112

Baron R, Binder A, Attal N, Casale R, Dickenson AH, Treede RD (2016) Neuropathic low back pain in clinical practice. Eur J Pain 20(6):861–873PubMedPubMedCentralCrossRef

Bing Z, Villanueva L, Le Bars D (1990) Acupuncture and diffuse noxious inhibitory controls: naloxone-reversible depression of activities of trigeminal convergent neurons. Neuroscience 37(3):809–818PubMedCrossRef

Bing Z, Cesselin F, Bourgoin S, Clot AM, Hamon M, Le Bars D (1991) Acupuncture-like stimulation induces a heterosegmental release of Met-enkephalin-like material in the rat spinal cord. Pain 47(1):71–77PubMedCrossRef

Butler DS, Moseley GL (2016) Schmerzen Verstehen, 3. Aufl. Springer, ISBN-13: 978-3662486573CrossRef

Chandran P, Sluka KA (2003) Development of opioid tolerance with repeated transcutaneous electrical nerve stimulation administration. Pain 102(1–2):195–201PubMedCrossRef

Chiang C (1974) A physical theory of acupuncture anesthesia. Physiol Chem Phys 6(1):85e86

Clifford DB, Simpson DM, Brown S, Moyle G, Brew BJ, Conway B, Tobias JK, Vanhove GFA (2012) Randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy. J Acquir Immune Defic Syndr 59(2):126–133PubMedCrossRef

Colloca L, Ludman T, Bouhassira D, Baron R, Dickenson AH, Yarnitsky D, Freeman R, Truini A, Attal N, Finnerup NB, Eccleston C, Kalso E, Bennett DL, Dworkin RH, Raja SN (2017) Neuropathic pain. Nat Rev Dis Primers 3:17002PubMedPubMedCentralCrossRef

Devor M (2009) Ectopic discharge in Aβ afferents as a source of neuropathic pain. Exp Brain Res 196(1):115–128PubMedCrossRef

Devor M, Wall PD (1978) Reorganisation of spinal cord sensory map after peripheral nerve injury. Nature 276(5683):75–76PubMedCrossRef

Dickenson AH (2002) Gate control theory of pain stands the test of time. Br J Anaesth 88(6):755–757PubMedCrossRef

García-Poblete E, Fernández-García H, Moro-Rodríguez E, Catalá-Rodríguez M, Rico-Morales ML, García-Gómez-de-las-Heras S, Palomar-Gallego MA (2003) Sympathetic sprouting in Dorsal Root Ganglia (DRG): a recent histological finding? Histol Histopathol 18:575–586PubMed

Gierthmühlen J, Baron R (2016) Neuropathic pain. Semin Neurol 36(5):462–468PubMedCrossRef

Gilron I, Baron R, Jensen T (2015) Neuropathic pain: principles of diagnosis and treatment. Mayo Clin Proc 90(4):532–545PubMedCrossRef

Han JS (2004) Acupuncture and endorphins. Neurosci Lett 361:258–261PubMedCrossRef

Han JS, Chen XH, Sun SL, Xu XJ, Yuan Y, Yan SC, Hao JX, Terenius L (1991) Effect of low- and high-frequency TENS on met-enkephalin-arg-phe and dynorphin a immunoreactivity in human lumbar CSF. Pain 47(3):295–298PubMedCrossRef

Han HC, Lee DH, Chung JM (2000) Characteristics of ectopic discharges in a rat neuropathic pain model. Pain 84(2–3):253–261PubMed

Handwerker HO (1998) Einführung in die Pathophysiologie des Schmerzes. Springer Verlag, ISBN-13: 978-3540627982

Handwerker HO, Iggo A, Ogawa H (1975) Dorsal horn neurones responding to cutaneous afferent input. J Physiol 244(1):1P–2PPubMed

Hebb ALO, Poulin JF, Roach SP, Zacharko RM, Drolet G (2005) Cholecystokinin and endogenous opioid peptides: interactive influence on pain, cognition, and emotion. Prog Neuro-Psychopharmacol Biol Psychiatry 29:1225–1238CrossRef

Heinricher MM, Neubert MJ (2004) Neural basis for the hyperalgesic action of cholecystokinin in the rostral ventromedial medulla. J Neurophysiol 92:1982–1989PubMedCrossRef

Hughes J, Kosterlitz HW (1983) Opioid peptides: introduction. Br Med Bull 39(1):1–3PubMedCrossRef

Hughes J, Kosterlitz HW, Smith TW (1997) The distribution of methionone-enkephalin and leucine-enkephaline in the brain and peripheral tissues. Br J Pharmacol 120(4 Suppl):428–436; discussion 426-7PubMedPubMedCentralCrossRef

Irving G, Backonja M, Rauck R, Webster LR, Tobias JK, Vanhove GF (2012) NGX-4010, a capsaicin 8% dermal patch, administered alone or in combination with systemic neuropathic pain medications, reduces pain in patients with postherpetic neuralgia. Clin J Pain 28(2):101–107PubMedCrossRef

Kosterlitz HW, Hughes J (1975) Some thoughts on the significance of enkephalin, the endogenous ligand. Life Sci 17(1):91–96PubMedCrossRef

Le Bars D (2002) The whole body receptive field of dorsal horn multireceptive neurones. Brain Res Rev 40(1–3):29–44PubMedCrossRef

Le Bars D, Willer JC (2002) Pain modulation triggered by high-intensity stimulation: implication for acupuncture analgesia. In: Sato A, Li P, Campbell J (Hrsg) Acupuncture – is there a physiological basis? International congress serie, Bd 1238. Elsevier, Amsterdam, S 11–29

Le Bars D, Villanueva L, Bouhassira D (1992) Willer. Diffuse Noxious Inhibitory Controls (DNIC) in animals and in man. JC Patol Fiziol Eksp Ter 4:55–65

Léonard G, Goffaux P, Marchand S (2010) Deciphering the role of endogenous opioids in high-frequency TENS using low and high doses of naloxone. Pain 151(1):215–219PubMedCrossRef

Leung L (2012) Neurophysiological basis of acupuncture-induced analgesia – an updated review. J Acupunct Meridian Stud 5(6):261–270PubMedCrossRef

Li CH, Yamashiro D, Tseng LF, Loh HH (1977) Synthesis and analgesic activity of human beta-endorphin. J Med Chem 20(3):325–328PubMedCrossRef

Liu XG, Morton CR, Azkue JJ, Zimmermann M, Sandkühler J (1998) Long-term depression of C-fibre-evoked spinal field potentials by stimulation of primary afferent Aδ-fibres in the adult rat. EJN 10(10):3069–3075PubMed

Louw A, Diener I, Butler DS, Puentedura EJ (2011) The effect of neuroscience education on pain, disability, anxiety, and stress in chronic musculoskeletal pain. Arch Phys Med Rehabil 92:2041–2056PubMedCrossRef

Louw A, Zimney K, O’Hotto C, Hilton S (2016) The clinical application of teaching people about pain. Physiother Theory Pract 5:385–395CrossRef

McMahon S, Koltzenburg M, Tracey I, Turk DC (2013) Wall & Melzack’s textbook of pain. W B Saunders Co Ltd, 6th Revised Edition, ISBN: 9780702040597

Melzack R, Casey KL (1968) Sensory, motivational, and central control determinants of pain. In: Kenshalo DR (Hrsg) The skin senses. Thomas, Springfield, IL, S 423–443

Melzack R, Wall P (1965) Pain mechanisms: a new theory. Science 150:3699CrossRef

Mendell LM (2014) Constructing and deconstructing the gate control theory of pain. Pain 155(2):210–216PubMedCrossRef

Moayedi M, Davis KD (2013) Theories of pain: from specificity to gate control. J Neurophysiol 109:5–12PubMedCrossRef

Moseley L (2002) Combined physiotherapy and education is efficacious for chronic low back pain. Aust J Physiother 48:297–302PubMedCrossRef

Moseley L (2003) A pain neuromatrix approach to patients with chronic pain. Man Ther 8(3):130–140PubMedCrossRef

Mosely L (2003) Unraveling the barriers to reconceptualization of the problem in chronic pain: the actual and perceived ability of patients and health professionals to understand the neurophysiology. J Pain 4:184–189CrossRef

Nafe JP (1929) A quantitative theory of feeling. J Gen Psychol 2(2–3):199–211CrossRef

Nilsson HJ, Schouenborg J (1999) Differential inhibitory effect on human nociceptive skin senses induced by local stimulation of thin cutaneous fibers. Pain 80:103–112PubMedCrossRef

Nilsson HJ, Psouni E, Schouenborg J (2003) Long term depression of human nociceptive skin senses induced by thin fibre stimulation. Eur J Pain 7(3):225–233PubMedCrossRef

van Nooten F, Treur M, Pantiri K, Stoker M, Charokopou M (2017) Capsaicin 8% patch versus oral neuropathic pain medications for the treatment of painful diabetic peripheral neuropathy: a systematic literature review and network meta-analysis. Clin Ther 39(4):787–803PubMedCrossRef

North RY, Lazaro TT, Dougherty PM (2018) Ectopic spontaneous afferent activity and neuropathic pain. Neurosurgery 65(1):49–54PubMedCrossRef

Ochs S (2004) A history of nerve functions: from animal spirits to molecular mechanisms. Cambridge University Press, ISBN 052124742XCrossRef

Otto J, Forstenpointner J, Binder A, Baron R (2019) Pharmakologische therapie chronischer neuropathischer schmerzen. Internist 60:711–723PubMedCrossRef

Price DD (2002) Central neural mechanisms that interrelate sensory and affective dimensions of pain. Mol Interv 6:392–403CrossRef

Ramer MS, Thompson SW, McMahon SB (1999) Causes and consequences of sympathetic basket formation in dorsal root ganglia. Pain Suppl 6:S111–S120PubMedCrossRef

Rey R (2005) A history of pain. Harvard University Press, Cambridge, MA, ISBN 0674399676

Reynolds J, Bilsky EJ, Meng ID (2011) Selective ablation of mu-opioid receptor expressing neurons in the rostral ventromedial medulla attenuates stress-induced mechanical hypersensitivity. Life Sci 89(9–10):313–319PubMed

Rufa A, Beissner K, Dolphin M (2019) The use of pain neuroscience education in older adults with chronic back and/or lower extremity pain. Physiother Theory Pract 35(7):603–613PubMed

Salar G, Job I, Mingrino S, Bosio A, Trabucchi M (1981) Effect of transcutaneous electrotherapy on CSF β-endorphin content in patients without pain problems. Pain 10:169–172PubMedCrossRef

Sandkühler J, Chen JG, Cheng G, Randić M (1997) Low-frequency stimulation of afferent Adelta-fibers induces long-term depression at primary afferent synapses with substantia gelatinosa neurons in the rat. J Neurosci 17(16):6483–6491PubMedPubMedCentralCrossRef

Sapolsky R. (2004) Why zebras don’t get ulcers. Holt paperbacks 3rd edn., ISBN-10: 0805073698

Sawynok J (2001) Antidepressants as analgetics: an overview of central and peripheral mechanisms of action. J Psychiatry Neurosci 26:21–29PubMedPubMedCentral

Schaible HG (2015) Pain control. Springer, Heidelberg, ISBN 978-3-662-46449-6CrossRef

Schnizer W, Kröling P, Claussen A, Magyarosy I (2003) Die Abschwächung (Desensibilisierung) des Galvanischen Erythems durch Wiederholte Gleichstromreizung. Phys Rehab Kurort Med 13(3):145–148CrossRef

Simone DA, Nolano M, Johnson T, Wendelschafer-Crabb G, Kennedy WR (1998) Intradermal injection of capsaicin in humans produces degeneration and subsequent reinnervation of epidermal nerve fibers: correlation with sensory function. J Neurosci 18(21):8947–8959PubMedPubMedCentralCrossRef

Sommer C, Leinders M, Üçeyler N (2018) Inflammation in the pathophysiology of neuropathic pain. Pain 159(3):595–602PubMedCrossRef

St John Smith E (2018) Advances in understanding nociception and neuropathic pain. J Neurol 265(2):231–238PubMedCrossRef

Todd AJ (2010) Neuronal circuitry for pain processing in the dorsal horn. Nat Rev Neurosci 1(12):823–836CrossRef

Villanueva L, Le Bars D (1995) The activation of bulbo-spinal controls by peripheral nociceptive inputs: diffuse noxious inhibitory controls. Biol Res 28(1):113–125PubMed

Wagman IH, Price DD (1969) Responses of dorsal horn cells of M. mulatta to cutaneous and sural nerve A and C fiber stimuli. J Neurophysiol 32(6):803–817

Watson JC, Sandroni P (2016) Central neuropathic pain syndromes. Mayo Clin Proc 91(3):372–385PubMedCrossRef

Weber M, Birklein F, Neundörfer B, Schmelz M (2001) Facilitated neurogenic inflammation in complex regional pain syndrome. Pain 91(3):251–257PubMedCrossRef

Wiesenfeld-Hallin Z, de Araúja LG, Alster P, Xu XJ, Hökfelt T (1999) Cholecystokinin / opioid interactions. Brain Res 848(1-2):78–89PubMedCrossRef

Wiesenfeld-Hallin Z, Xu XJ, Hökfelt T (2002) The role of spinal cholecystokinin in chronic pain states. Pharmacol Toxicol 91:398–403PubMedCrossRef

Winter J, Bevan S, Campbell EA (1995) Capsaicin and pain mechanisms. Br J Anaesth 75(2):157–168

Woolf CJ, Shortland P, Coggeshall RE (1992) Peripheral nerve injury triggers central sprouting of myelinated afferents. Nature 355:75–78PubMedCrossRef

Titel: Schmerz und Schmerzhemmung
verfasst von: Pieter van Kerkhof
Verlag: Springer Berlin Heidelberg
Buch: Evidenzbasierte Elektrotherapie
Print ISBN: 978-3-662-63535-3

Electronic ISBN: 978-3-662-63536-0

Copyright-Jahr: 2022
DOI: https://doi.org/10.1007/978-3-662-63536-0_2

Springerpflege

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten